Probiotics promoted head growth in extremely low birthweight infants in a double-blind placebo-controlled trial

Acta Paediatrica, International Journal of Paediatrics

Volumn 108, Issue 1, 2019, Pages 62-69

  Wejryd, Erik ^a   Marchini, Giovanna ^b   Frimmel, Veronica ^b   Jonsson, Baldvin ^b   Abrahamsson, Thomas ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Feeding tolerance; Growth; Necrotising enterocolitis; Premature infants; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; CHILD GROWTH; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GROWTH RATE; HEAD; HEAD CIRCUMFERENCE; HUMAN; INFANT; LACTOBACILLUS REUTERI; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; CEPHALOMETRY; CHILD DEVELOPMENT; DIETARY SUPPLEMENT; ENTERIC FEEDING; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; NEONATAL INTENSIVE CARE UNIT; NEWBORN; NONPARAMETRIC TEST; PHYSIOLOGY; PROCEDURES; REFERENCE VALUE; RISK ASSESSMENT; SWEDEN; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

CEPHALOMETRY; CHILD DEVELOPMENT; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FEMALE; GESTATIONAL AGE; HEAD; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; LACTOBACILLUS REUTERI; MALE; PROBIOTICS; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SWEDEN; TREATMENT OUTCOME;

EID: 85052536038     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.14497     Document Type: Article

References (29)

1. Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006; 117: 1253–61
2. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014; 4: CD005496
3. Abrahamsson TR, Rautava S, Moore AM, Neu J, Sherman PM. The time for a confirmative necrotizing enterocolitis probiotics prevention trial in the extremely low birth weight infant in North America is now!. J Pediatr 2014; 165: 389–94
4. Wu RY, Pasyk M, Wang B, Forsythe P, Bienenstock J, Mao YK, et al. Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Neurogastroenterol Motil 2013; 25: e205–14
5. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr 2008; 152: 801–6
6. Stoltz Sjöström E, Öhlund I, Ahlsson F, EngstrÖm E, Fellman V, Hellström A, et al. Nutrient intakes independently affect growth in extremely preterm infants: results from a population-based study. Acta Paediatr 2013; 102: 1067–74
7. Hansen-Pupp I, Lofqvist C, Polberger S, Niklasson A, Fellman V, Hellstrom A, et al. Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants. Pediatr Res 2011; 69: 448–53
8. Franz AR, Pohlandt F, Bode H, Mihatsch WA, Sander S, Kron M, et al. Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support. Pediatrics 2009; 123: e101–9
9. Bienenstock J, Kunze W, Forsythe P. Microbiota and the gut-brain axis. Nutr Rev 2015; 73(Suppl 1): 28–31
10. Heijtz RD, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011; 108: 3047–52
11. Buffington SA, Di Prisco GV, Auchtung TA, Ajami NJ, Petrosino JF, Costa-Mattioli M. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 2016; 165: 1762–75
12. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155: 1451–63
13. Agustina R, Bovee-Oudenhoven IM, Lukito W, Fahmida U, van de Rest O, Zimmermann MB, et al. Probiotics Lactobacillus reuteri DSM 17938 and Lactobacillus casei CRL 431 modestly increase growth, but not iron and zinc status, among Indonesian children aged 1-6 years. J Nutr 2013; 143: 1184–93
14. Romeo MG, Romeo DM, Trovato L, Oliveri S, Palermo F, Cota F, et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 2011; 31: 63–9
15. Oncel MY, Sari FN, Arayici S, Guzoglu N, Erdeve O, Uras N, et al. Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2014; 99: F110–5
16. Niklasson A, Albertsson-Wikland K. Continuous growth reference from 24th week of gestation to 24 months by gender. BMC Pediatr 2008; 8: 8
17. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187: 1–7
18. de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992; 49: 1–6
19. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123: 991–9
20. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529–34
21. Dsilna A, Christensson K, Alfredsson L, Lagercrantz H, Blennow M. Continuous feeding promotes gastrointestinal tolerance and growth in very low birth weight infants. J Pediatr 2005; 147: 43–9
22. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013; 132: 1055–62
23. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016; 387: 649–60
24. Eaton S, Rees CM, Hall NJ. Current research on the epidemiology, pathogenesis, and management of necrotizing enterocolitis. Neonatology 2017; 111: 423–30
25. Serenius F, Ewald U, Farooqi A, Fellman V, Hafstrom M, Hellgren K, et al. Neurodevelopmental outcomes among extremely preterm infants 6.5 years after active perinatal care in Sweden. JAMA Pediatr 2016; 170:954–63
26. O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 2015; 277: 32–48
27. Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 2016; 22: 598–605
28. Marsland BJ. Regulating inflammation with microbial metabolites. Nat Med 2016; 22: 581–3
29. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011; 60: 307–17